Bioelectric Medicine Development Summit

2024 has just started and Cognito Therapeutics has reached a clinical milestone with their neuromod device, Medtronic’s closed loop SCS has successfully reduced overstimulation and SPR Therapeutics’ SPRINT PNS demonstrated efficacy!

As leading device developers optimize their strategies and start-ups continue to grow, this explosive field is witnessing greater recognition and the potential to redefine the possibilities of bioelectric medicine to be used as a routine therapy is here.

Coming to you in Boston, the Bioelectric Medicine Development Summit is the only industry forum dedicated to uniting likeminded experts to:

-Cultivate this rapidly growing field by overcoming the competition and leveraging different perspectives into advancing DBS, VNS, BCI, SCS and more

-Convince key stakeholders of its monumental potential by understanding physicians, patients, venture capitals and insurance companies’ requirements

-Create an intimate environment to confidently share successes and setbacks to unite towards a shared goal of advancing the bioelectric medicine field forward

Don’t miss out on your opportunity to be at the forefront of a transformative industry with 80+ neurostimulation experts from LivaNova, FDA, Boomerang Medical, Axonics, NeuSpera, Sinaptica Therapeutics, Saluda Medical, SPR Therapeutics and many more to discover novel strategies in obtaining funding, shortening clinical trials, approaching regulatory bodies, and overcoming reimbursement barriers.

URLs:

Tickets: https://go.evvnt.com/2237554-2?pid=91 

Brochure: https://go.evvnt.com/2237554-3?pid=91 

Prices:

Drug Developer Conference + Pre-Conference Workshop Day Ticket: USD 4197.00,

Drug Developer Conference Only Ticket: USD 2999.00,

Academic Conference + Pre-Conference Workshop Day Ticket: USD 3597.00,

Academic Conference Only Ticket: USD 2599.00,

Solution Provider Conference + Pre-Conference Workshop Day Ticket: USD 5097.00,

Solution Provider Conference Only Ticket: USD 3699.00

Speakers: Alex Yeh Founder, Chief Technology Officer and Vice President Research and Development, NeuSpera, Anuj Bhardwaj Founder and CEO, SecondWave Systems, Bryan McLaughlin, Founder and Chief Executive Officer, Micro-Leads, David Miller, Chief Technology and Innovation Officer, Co-founder, Boomerang Medical, Greg Alden, Chief Executive Officer, Diagnostic Biochips Inc., Imran Eba, Partner, Action Potential Learning LLC, Josh Boggs, Chief Scientific Officer, SPR Therapeutics, Kate Rosenbluth, Co-President and Chief Scientific Officer, Cala Health Inc., Katherine Neuenfeldt, Senior Vice President, Commercial Strategies, Presidio Medical, Kathryn Nichol, Co-Founder and Chief, LivaNova, Keith Warner, Chief Executive Officer, NeuraLace Medical, Ken Mariash, Chief Executive Officer, Sinpatica Therapeutics, Mary McNamara-Cullinane, Vice President of Regulatory Affairs, ClearPoint Neuro Inc., Ralph Kern, Chief Medical Officer, Cognito Therapeutics Inc., Raymond W. Cohen, CEO, Axonics, Inc., Shyamy Sastry, Chief Executive Officer, Synpatix Bio, Steven Mcquillan, Chief Clinical Officer, Saluda Medical, Vivek Pinto, Director, Division of Neuromodulation and Physical Medicine Devices, CDRH, FDA, William Phillips, Managing Partner, Alruna Advisors